JUL 2013

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/146899

Contents of this Issue


Page 27 of 66

DUREZOL® Emulsion now has head-to-head data vs prednisolone acetate in patients with endogenous anterior uveitis.1 Scan the QR code with your smartphone or log on to www.infammationhappens.com to see the results for yourself. INDICATIONS AND USAGE: DUREZOL® Emulsion is a topical corticosteroid that is indicated for the treatment of endogenous anterior uveitis. Dosage and Administration For the treatment of endogenous anterior uveitis, instill one drop into the conjunctival sac of the affected eye 4 times daily for 14 days followed by tapering as clinically indicated. IMPORTANT SAFETY INFORMATION Contraindications: DUREZOL® Emulsion, as with other ophthalmic corticosteroids, is contraindicated in most active viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. Warnings and Precautions tOUSBPDVMBSQSFTTVSF*01 JODSFBTFo1SPMPOHFEVTFPGDPSUJDPTUFSPJETNBZ * result in glaucoma with damage to the optic nerve, defects in visual acuity BOEGJFMETPGWJTJPO*GUIJTQSPEVDUJTVTFEGPSEBZTPSMPOHFS *01TIPVME be monitored. t BUBSBDUTo6TFPGDPSUJDPTUFSPJETNBZSFTVMUJOQPTUFSJPSTVCDBQTVMBS $ cataract formation. t FMBZFEIFBMJOHo5IFVTFPGTUFSPJETBGUFSDBUBSBDUTVSHFSZNBZEFMBZ % IFBMJOHBOEJODSFBTFUIFJODJEFODFPGCMFCGPSNBUJPO*OUIPTFEJTFBTFT causing thinning of the cornea or sclera, perforations have been known to PDDVSXJUIUIFVTFPGUPQJDBMTUFSPJET5IFJOJUJBMQSFTDSJQUJPOBOESFOFXBM of the medication order beyond 28 days should be made by a physician only after examination of the patient with the aid of magnification such as slit lamp biomicroscopy and, where appropriate, fluorescein staining. Reference: 1. DUREZOL® Emulsion Package Insert. ©2012 Novartis 6/12 DUR12020JAD t BDUFSJBMJOGFDUJPOTo1SPMPOHFEVTFPGDPSUJDPTUFSPJETNBZTVQQSFTT # the host response and thus increase the hazard of secondary ocular JOGFDUJPOT*OBDVUFQVSVMFOUDPOEJUJPOT TUFSPJETNBZNBTLJOGFDUJPO PSFOIBODFFYJTUJOHJOGFDUJPO*GTJHOTBOETZNQUPNTGBJMUPJNQSPWF after 2 days, the patient should be re-evaluated. t JSBMJOGFDUJPOTo&NQMPZNFOUPGBDPSUJDPTUFSPJENFEJDBUJPOJOUIF 7 treatment of patients with a history of herpes simplex requires great caution. Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex). t VOHBMJOGFDUJPOTo'VOHBMJOGFDUJPOTPGUIFDPSOFBBSFQBSUJDVMBSMZ ' prone to develop coincidentally with long-term local steroid application. Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use. t POUBDUMFOTXFBSo%63&;0-® Emulsion should not be instilled while $ wearing contact lenses. Adverse Reactions *OUIFFOEPHFOPVTBOUFSJPSVWFJUJTTUVEJFT UIFNPTUDPNNPOBEWFSTF SFBDUJPOTPDDVSSJOHJOPGTVCKFDUTJODMVEFECMVSSFEWJTJPO FZF JSSJUBUJPO FZFQBJO IFBEBDIF JODSFBTFE*01 JSJUJT MJNCBMBOEDPOKVODUJWBM hyperemia, punctate keratitis, and uveitis. For additional information about DUREZOL® Emulsion please refer to the brief summary of prescribing information on adjacent page.

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - JUL 2013